Stock Researching

Gilead Sciences' Tybost Approved By European Commission

Stock Researching
Publish date: Thu, 26 Sep 2013, 09:30 AM
Stockresearching is a blog designed to help the independent investor create new ideas and receive valuable informed information.

From Liston Street Pulse:

Gilead Sciences Inc. (GILD) said on Wednesday that the European Commission has approved its once-a-day drug Tybost. Tybost is a pharmacokinetic enhancer; meant to improve blood levels of certain HIV treatments. The drug is seen boosting agent for the HIV protease inhibitors (atazanavir 300 mg once daily and darunavir 800 […]

The post Gilead Sciences' Tybost Approved By European Commission appeared first on Liston Street Pulse.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment